Roflumilast Attenuates Doxorubicin-Induced Cardiotoxicity by Targeting Inflammation and Cellular Senescence in Cardiomyocytes Mediated by SIRT1Sheng Zhang, Zhijian Yang|Drug Design Development and Therapy|2021Cited by 30